The Executive Chairperson of Biocon, Kiran Mazumdar Shaw recently through social media platform Twitter announced that she has tested positive for the novel coronavirus. In her tweet informing the people of her health, the 67-year old biotech industry veteran said, “I have added to the COVID count by testing positive. Mild symptoms n I hope…
Biocon Ltd, an innovation-led global biopharmaceuticals company, announced that it has received the Drugs Controller General of India’s (DCGI) approval to market Itolizumab (ALZUMAb) Injection 25mg/5mL solution for emergency use in India for the treatment of cytokine release syndrome (CRS) in moderate to severe ARDS (acute respiratory distress syndrome) patients due to COVID-19. Itolizumab is…
Biocon Ltd. and Biocon Biologics have activated business continuity plans across their functions to meet the needs of patients, partners, customers and other stakeholders who depend on its products. As a global company, it has presence across India, UAE, Malaysia, Singapore, Europe, U.S. and are adjusting all operations to fully comply with regulations issued by…